Trials / Completed
CompletedNCT04862559
A Single Center Study to Evaluate the Safety of the NovaCross Microcatheter in Crossing Chronic Total Occlusions
A Prospective, Single Center, Non-randomized, Single Arm, Open Label, Study to Evaluate the Safety and Effectiveness of the NovaCross™ Micro-catheter in Facilitating Crossing Chronic Total Occlusion (CTO) Coronary Lesions
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Nitiloop Ltd. · Industry
- Sex
- All
- Age
- 25 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is an open label, single-center, prospective, pivotal study in which the investigational device, NovaCross™ micro-catheter, will be tested in up to 15 patients scheduled to undergo CTO-PCI using an anterograde approach.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NovaCross | A device that is intended to asisst interventional cardiologists during catheterization to cross and open coronary chronic total occlusions |
Timeline
- Start date
- 2017-02-01
- Primary completion
- 2017-09-17
- Completion
- 2017-09-17
- First posted
- 2021-04-28
- Last updated
- 2021-04-28
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT04862559. Inclusion in this directory is not an endorsement.